Drugmakers Blame Middlemen for High Prices But Still Make Huge Profits

Feb 05, 2019 - Fortune

With drug prices climbing far faster than inflation, the cost of prescription medicine has become a big issue in the U.S. They are the third highest expense in the U.S. health care system and 9.5% of the total cost, according to figures from the Centers for Medicare & Medicaid Services.

There’s heat from politicians and drugmakers don’t like it. In the past, pharmaceutical companies argued that high prices were necessary to fund of research. Now they’re pointing at drug middlemen, as...